CPhI Worldwide Opens Entries for 15th Annual Pharma Awards
CPhI Worldwide has announced the opening of the 2018 CPhI Pharma Awards for entries. The awards will be presented in 17 categories honouring companies and individuals driving the pharmaceutical industry forward through innovations, technologies, and strategies.
The awards will recognise ‘Excellence in Pharma’ in 17 categories: API Development; Formulation; Excipients; Manufacturing Technology and Equipment; Bioprocessing and Manufacturing; Analysis, Testing, and Quality Control; Drug Delivery Devices; Packaging; Supply Chain, Logistics, and Distribution; Contract Services and Outsourcing; Regulatory Procedures and Compliance; Corporate Social Responsibility; CEO of the Year; Pharma Company of the Year; OTC; Patient Centricity; and IT, mHealth & Digitalisation.
Last year, the awards received a record number of over 200 applications, and CPhI Worldwide is expecting greater interest in 2018. Amongst 2017’s most hotly contested categories were API Development, Product Packaging and Drug Delivery and Devices categories, which each received over 20 high-quality entries.
Winners of the CEO of the Year award feature a ‘who’s who’ of executives: Mr. Vivek Sharma, CEO, Piramal (2015); Mr. Udit Batra, CEO, Merck (2016), and Dr. Richard Chin, founder & CEO of Kindred Biosciences (2017).
Deadline for submitting entries is July 31, 2018, and the winners will be unveiled on October 9 during the evening of the first day of CPhI Worldwide in Madrid.
2026-08-21
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI & PMEC China 2023: A Global Pharmaceutical Industry Exchange and Cooperation Platform
-
【CPHI China 2023】Day 3 -- The CPHI China exhibition has come to a successful end, and Echemi has received high praise and recognition.
-
【CPHI China 2023】Day 2 -- Echemi teams up with CPHI China to hold overseas buyer matching event, helping pharmaceutical companies expand into international markets.
-
【CPHI China 2023】Day 1 -- ECHEMI.com helps transform and upgrade the pharmaceutical industry
-
CPhI Japan postponed until April 2021
-
CPhI Discover
-
2020 World Pharmaceutical Raw Materials Exhibition, another country cancelled
-
2019 CPhI Worldwide Special Report
-
2019 ECHEMI Natural Extracts Sourcing Meeting Recap
-
2019 CPhI Agencies Updates and Q&A (Excipients)
Recommend Reading
-
Chung Lien Oil’s 8,000-Ton Soybean Oil BaP Scandal: NT$165 Million Fine, 401 Product Recalls, Source Still Unknown
-
From Coffee Waste to Superfood Additive: EU Declares Pectin-Rich Arabica Extract Safe for Food Use
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
Australia Approves Lab-Grown “Milk Sugar” for Babies—A Breakthrough in Infant Nutrition
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
Premium Global Chemical Sourcing Requests (10-14 Jan, 2026)
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
On January 15, China's titanium dioxide market remains firm and upward
-
In December, the ammonium sulfate market in China showed a weak downward trend